Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2025 MedTech Innovation Spotlight
Inspire is scheduled to present at 12:00 p.m. Eastern Time. The presentation will be accessible via a live webcast here.
A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire's Investor website at https://investors.inspiresleep.com.
About Inspire Medical SystemsInspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media ContactEzgi YagciVice President, Investor Relationsezgiyagci@inspiresleep.com617-549-2443Sign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
8 minutes ago
- Bloomberg
NYSE's Martin Says IPO Market Open for ‘Pretty Much All Sectors'
The market for initial public offerings is open for companies in 'pretty much all sectors,' with firms benefiting from waiting for their IPOs, New York Stock Exchange President Lynn Martin said. 'The companies that come to market are better companies,' Martin said in a Bloomberg Television interview Monday. 'You look at the companies that have gone public, it's not the first time they have been in the news about an IPO. Look at Circle, for example.'
Yahoo
12 minutes ago
- Yahoo
Lumen Technologies, Inc. Announces Offering of First Lien Notes Due 2034
DENVER, August 04, 2025--(BUSINESS WIRE)--Lumen Technologies, Inc. ("Lumen," "us," "we" or "our") (NYSE: LUMN) today announced that its wholly-owned subsidiary, Level 3 Financing, Inc. ("Level 3 Financing"), plans to offer $1.25 billion aggregate principal amount of First Lien Notes due 2034 (the "First Lien Notes"). Level 3 Financing intends to use the net proceeds from this offering, together with cash on hand, to partially redeem $1,075,000,000 aggregate principal amount of Level 3 Financing's 11.000% First Lien Notes due 2029, including payment of redemption premium, and to pay related fees and expenses. The First Lien Notes will not be registered under the Securities Act of 1933 (the "Securities Act") or any state securities laws in the United States and may not be offered or sold in the United States absent registration or an exemption from the applicable registration requirements. Accordingly, the First Lien Notes are being offered and sold only to persons reasonably believed to be qualified institutional buyers in accordance with Rule 144A promulgated under the Securities Act and to non-U.S. persons outside the United States in accordance with Regulation S promulgated under the Securities Act. The First Lien Notes will not have registration rights. This press release does not constitute an offer to sell, or a solicitation of an offer to buy, the First Lien Notes, nor will there be any sale of the First Lien Notes in any jurisdiction in which such offer, solicitation or sale would be unlawful. This press release does not constitute a notice of redemption with respect to any of Level 3 Financing's outstanding senior notes. About Lumen Lumen is unleashing the world's digital potential. We ignite business growth by connecting people, data, and applications – quickly, securely, and effortlessly. As the trusted network for AI, Lumen uses the scale of our network to help companies realize AI's full potential. From metro connectivity to long-haul data transport to our edge cloud, security, managed service, and digital platform capabilities, we meet our customers' needs today and as they build for tomorrow. Lumen and Lumen Technologies are registered trademarks of Lumen Technologies LLC in the United States. Forward-Looking Statements Except for historical and factual information, the matters set forth in this release and other of our oral or written statements identified by words such as "estimates," "expects," "anticipates," "believes," "plans," "intends," and similar expressions are forward-looking statements. These forward-looking statements are not guarantees of future results and are based on current expectations only, are inherently speculative, and are subject to a number of assumptions, risks and uncertainties, many of which are beyond our control. Actual events and results may differ materially from those anticipated, estimated, projected or implied by us in those statements if one or more of these risks or uncertainties materialize, or if underlying assumptions prove incorrect. Factors that could affect actual results include, but are not limited to: the possibility that potential debt investors will not be receptive to the offering on the terms described above or at all; corporate developments that could preclude, impair or delay the above-described transactions due to restrictions under the federal securities laws; changes in Level 3 Financing's credit ratings; changes in the cash requirements, financial position, financing plans or investment plans of Level 3 Financing or its affiliates; changes in general market, economic, tax, regulatory or industry conditions that impact the ability or willingness of Level 3 Financing or its affiliates to consummate the above-described transactions on the terms described above or at all; and other risks referenced from time to time in the filings of Lumen or Level 3 Parent, LLC with the Securities and Exchange Commission. We undertake no obligation to publicly update or revise any forward-looking statements for any reason, whether as a result of new information, future events or developments, changed circumstances, or otherwise. We may change our intentions, strategies or plans (including our plans expressed herein) without notice at any time and for any reason. View source version on Contacts Media Contact:Joe +1 781-799-6048 Investor Contact: Jim Breen, +1 603-404-7003 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
35 minutes ago
- Yahoo
Wayfair Soars As Shoppers Spend Big And Profits Grow
Wayfair (NYSE:W) shares are trading higher on Monday after reporting second-quarter results. The e-commerce company reported adjusted earnings per share of 87 cents, beating the street view of 32 cents. Quarterly sales of $3.27 billion (up by 5% year-over-year or Y/Y) outpaced the analyst consensus estimate of $3.12 billion. Total net revenue, excluding the impact of our exit from the German market, grew 6.0% Y/Y.U.S. net revenue rose 5.3% Y/Y to $2.9 billion. International net revenue rose 3.1% Y/Y to $399 million. On a constant currency basis, international revenue grew 2.1% Y/Y. Gross profit in the quarter under review increased to $984 million, higher than $941 million in the year-ago period. View more earnings on W As of June 30, active customers totaled 21.0 million, a decrease of 4.5% Y/Y. Orders delivered in the quarter were 10.0 million, flat Y/Y. Average order value was $328 in the quarter, compared to $313 Y/Y. Adjusted EBITDA in the quarter under review increased to $205 million, higher than $163 million a year ago. Adjusted EBITDA Margin expanded to 6.3% from 5.2% a year ago. Cash, cash equivalents, and short-term investments totaled $1.4 billion, and total liquidity was $1.8 billion, including availability under the company's revolving credit facility. Wayfair CEO Niraj Shah reported that the second quarter delivered strong results, accelerating sales, market share gains, and improved profitability. He highlighted that, excluding Germany, revenue grew 6% Y/Y, Wayfair's fastest pace since early 2021, while adjusted EBITDA margin exceeded 6%, reflecting significant operating leverage and progress toward long-term financial goals outlined during the company's investor day. He expressed optimism for continued momentum through 2025 and beyond. Price Action: Wayfair shares are trading higher by 11.9% to $73.00 premarket at last check Monday. Image via Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? WAYFAIR (W): Free Stock Analysis Report This article Wayfair Soars As Shoppers Spend Big And Profits Grow originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.
